Morishima Y - Search Results

1

Sensory evaluation of edoxaban orally disintegrating tablets: an open-label interventional study (secondary publication).

Yamashita T, Hagii J, Morishima Y, Akasaka T, Matsumoto T, Kimura T. Yamashita T, et al. Among authors: morishima y. Thromb J. 2019 Feb 15;17:3. doi: 10.1186/s12959-019-0192-x. eCollection 2019. Thromb J. 2019. PMID: 30814914 Free PMC article.

2

The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats.

Morishima Y, Kamisato C, Honda Y, Furugohri T, Shibano T. Morishima Y, et al. Thromb Res. 2013 Jan;131(1):59-63. doi: 10.1016/j.thromres.2012.08.304. Epub 2012 Sep 19. Thromb Res. 2013. PMID: 22999414

3

Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin.

Fukuda T, Kamisato C, Honda Y, Matsushita T, Kojima T, Furugohri T, Morishima Y, Shibano T. Fukuda T, et al. Among authors: morishima y. Thromb Res. 2013 Jun;131(6):540-6. doi: 10.1016/j.thromres.2013.04.016. Epub 2013 May 11. Thromb Res. 2013. PMID: 23673387

4

A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.

Morishima Y, Honda Y. Morishima Y, et al. J Thromb Thrombolysis. 2018 Jul;46(1):95-101. doi: 10.1007/s11239-018-1673-7. J Thromb Thrombolysis. 2018. PMID: 29704172

5

Responses of prothrombin time and activated partial thromboplastin time to edoxaban in Japanese patients with non-valvular atrial fibrillation: characteristics of representative reagents in Japan (CVI ARO 7).

Suzuki S, Morishima Y, Takita A, Yagi N, Otsuka T, Arita T, Yamashita T. Suzuki S, et al. Among authors: morishima y. Heart Vessels. 2019 Dec;34(12):2011-2020. doi: 10.1007/s00380-019-01438-6. Epub 2019 May 23. Heart Vessels. 2019. PMID: 31123819

6

Association between plasma concentration of edoxaban determined by direct and indirect methods in Japanese patients with non-valvular atrial fibrillation (CVI ARO 7).

Suzuki S, Morishima Y, Takita A, Otsuka T, Yagi N, Arita T, Yamashita T. Suzuki S, et al. Among authors: morishima y. Heart Vessels. 2020 Mar;35(3):409-416. doi: 10.1007/s00380-019-01501-2. Epub 2019 Sep 14. Heart Vessels. 2020. PMID: 31522245

7

Exploratory Analysis of Circulating miRNA Signatures in Atrial Fibrillation Patients Determining Potential Biomarkers to Support Decision-Making in Anticoagulation and Catheter Ablation.

Kiyosawa N, Watanabe K, Morishima Y, Yamashita T, Yagi N, Arita T, Otsuka T, Suzuki S. Kiyosawa N, et al. Among authors: morishima y. Int J Mol Sci. 2020 Apr 1;21(7):2444. doi: 10.3390/ijms21072444. Int J Mol Sci. 2020. PMID: 32244749 Free PMC article.

8

Effects of concomitant use of prasugrel with edoxaban on bleeding time, pharmacodynamics, and pharmacokinetics of edoxaban in healthy elderly Japanese male subjects: a clinical pharmacology study.

Ikushima I, Akasaka T, Morishima Y, Takita A, Motohashi T, Kimura T. Ikushima I, et al. Among authors: morishima y. Thromb J. 2020 Jun 12;18:10. doi: 10.1186/s12959-020-00223-0. eCollection 2020. Thromb J. 2020. PMID: 32536828 Free PMC article.

9

D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.

Kida K, Nabeta T, Ishida M, Shiono T, Suzuki N, Doi S, Tsukahara M, Ohta Y, Kimura T, Morishima Y, Takita A, Matsumoto N, Akashi YJ, Ako J, Inomata T. Kida K, et al. Among authors: morishima y. J Cardiol. 2022 Jun;79(6):759-767. doi: 10.1016/j.jjcc.2022.01.005. Epub 2022 Feb 9. J Cardiol. 2022. PMID: 35148920 Free article.

10

Frailty and outcomes in older adults with non-valvular atrial fibrillation from the ANAFIE registry.

Akishita M, Suzuki S, Inoue H, Akao M, Atarashi H, Ikeda T, Koretsune Y, Okumura K, Shimizu W, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Teramukai S, Kimura T, Morishima Y, Takita A, Yamashita T. Akishita M, et al. Among authors: morishima y. Arch Gerontol Geriatr. 2022 Jul-Aug;101:104661. doi: 10.1016/j.archger.2022.104661. Epub 2022 Feb 19. Arch Gerontol Geriatr. 2022. PMID: 35303601 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

921 results

Search Page

Filters